| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2014028080 |
| Title |
Treatment of Prostate Cancer and Hematologic Neoplasms. |
| Abstract |
Prostate cancer and hematological neoplasms are treated by administration of (i) a compound of Formula I: wherein: R1 is -OH or -O-P(O)(OH)2; and R2is (II) or (III); (ii) N6-benzyladenosine, (iii) N-(phenylmethyl)-7-gama-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, (iv) N-(phenylmethyl)-7-gama-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 5'-monophosphate; or a pharmaceutically acceptable salt thereof. |
| Applicant(s) |
Thomas Jefferson University |
| Representative Drug(s) |
D02MAG |
Drug Info
|
N.A. |
[1] |
| Patent ID |
WO2009039199 |
| Title |
Compositions Comprising Stat5 Sirna and Methods of Use Thereof. |
| Abstract |
The present invention provides nucleic acid molecules that inhibit STAT5 expression. Methods of using the nucleic acid molecules are also provided. |
| Applicant(s) |
INTRADIGM CORPORATION XIE, Frank, Y. YANG, Xiaodong LIU, Ying |
| United States Patent and Trademark Office (USPTO) |
| Patent ID |
US20130210834 |
| Title |
Indirubin Derivatives and Uses for Treating Chronic Myelogenous Leukemia. |
| Applicant(s) |
City of Hope, Durate, Ca |
| Representative Drug(s) |
D0T8PK |
Drug Info
|
N.A. |
[1] |
